Carole Ben-Maimon - 11 Nov 2026 Form 4 Insider Report for Larimar Therapeutics, Inc. (LRMR)

SEC form
4
Accepted by SEC
12 Nov 2026, 18:02:53 UTC
Prior SEC filing
27 Jan 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Carole Ben-Maimon filed Form 4 for Larimar Therapeutics, Inc. (LRMR) on 12 Nov 2026.

Key facts

  • This page summarizes Carole Ben-Maimon's Form 4 filing for Larimar Therapeutics, Inc. (LRMR).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 12 Nov 2026, 18:02.

Change

  • Previous filing in this sequence was filed on 27 Jan 2026.
  • Current net transaction value: +$49,953.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001529611 Primary reporting owner

BEN-MAIMON CAROLE

Relationship
President and CEO, Director

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LRMR transaction

Common Stock

Purchase

Transaction value
$49,953
Shares
+18,050
Change %
+4.9%
Price
$2.77
Shares after
386,326
Date
11 Nov 2026
Ownership
Direct
Footnotes
F1, F2
LRMR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
31,155
Date
11 Nov 2026
Ownership
By Trust
Footnotes
F3
LRMR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
31,155
Date
11 Nov 2026
Ownership
By Trust
Footnotes
F4
LRMR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
31,156
Date
11 Nov 2026
Ownership
By Trust
Footnotes
F5
LRMR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
31,156
Date
11 Nov 2026
Ownership
By Trust
Footnotes
F6
LRMR holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
31,156
Date
11 Nov 2026
Ownership
By Trust
Footnotes
F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.765 to $2.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.

Footnote F3

Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Meadow Lainey Ben-Maimon ("Meadow Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Meadow Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.

Footnote F4

Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Olivia Liat Stein ("Olivia Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Olivia Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.

Footnote F5

Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Ella Bar Stein ("Ella Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Ella Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.

Footnote F6

Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Romi Aleeza Stein ("Romi Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Romi Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.

Footnote F7

Represents shares held by the Irrevocable Deed of Trust of Carole S. Ben-Maimon for the Benefit of Matzi Mark Ben-Maimon ("Matzi Trust"), of which the Reporting Person serves as trustee. The Reporting Person disclaims Section 16 beneficial ownership of the shares held by the Matzi Trust except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed to be an admission that she has beneficial ownership of such shares for Section 16 or any other purpose.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .